The Communicator Quarterly Newsletter Myasthenia Gravis 1/22/23 Quarterly Newsletter Myasthenia Gravis 1/22/23 Winter 2022 Antigen-Specific Treatment of Myasthenia: Chimeric Autoantibody Receptor T Cells Read More
Quarterly Newsletter Myasthenia Gravis 1/22/23 Quarterly Newsletter Myasthenia Gravis 1/22/23 Winter 2022 Antigen-Specific Treatment of Myasthenia: Chimeric Autoantibody Receptor T Cells Read More